The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is unknown. The objective of this study was to investigate the effect of appropriate therapy and of appropriate combination therapy on mortality of patients with bloodstream infections (BSIs) due to CPE
The primary objective was to describe clinical features, treatment and outcomes in patients with car...
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and repre...
Background: Carbapenem resistant Enterobacteriaceae (CRE) has become a serious public health problem...
Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is ...
Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is ...
Background: Blood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) are ...
SummaryBackgroundBlood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE)...
Background: Blood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) are ...
<p>Outcome of patients with carbapenemase-producing <i>Enterobacteriaceae</i> bloodstream infection ...
Abstract Background To describe the clinical and microbiological data of carbapenem-resistant Entero...
The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) has increased during the past 10 ...
Objective To develop a score to predict mortality in patients with bloodstream infections (BSIs) due...
Abstract\ud \ud Background\ud To describe the clinical...
Objective. To investigate the risk factors underlying the occurrence and mortality of bloodstream in...
The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) has increased during the past 10 ...
The primary objective was to describe clinical features, treatment and outcomes in patients with car...
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and repre...
Background: Carbapenem resistant Enterobacteriaceae (CRE) has become a serious public health problem...
Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is ...
Background The best available treatment against carbapenemase-producing Enterobacteriaceae (CPE) is ...
Background: Blood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) are ...
SummaryBackgroundBlood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE)...
Background: Blood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) are ...
<p>Outcome of patients with carbapenemase-producing <i>Enterobacteriaceae</i> bloodstream infection ...
Abstract Background To describe the clinical and microbiological data of carbapenem-resistant Entero...
The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) has increased during the past 10 ...
Objective To develop a score to predict mortality in patients with bloodstream infections (BSIs) due...
Abstract\ud \ud Background\ud To describe the clinical...
Objective. To investigate the risk factors underlying the occurrence and mortality of bloodstream in...
The prevalence of carbapenemase-producing Enterobacteriaceae (CPE) has increased during the past 10 ...
The primary objective was to describe clinical features, treatment and outcomes in patients with car...
In recent years, carbapenem resistance among Enterobacteriaceae has dramatically increased and repre...
Background: Carbapenem resistant Enterobacteriaceae (CRE) has become a serious public health problem...